|
|
 |
|
“From start to
finish I’ve been impressed with
Oxford’s professionalism,
competence, courtesy, focus,
tenacity and responsiveness.
Very few organizations have
impressed me as much in my 30
plus years in the business.”
James Andrews,
Vice President & Chief Financial
Officer AngioScore
|
|
|
|
 |
|
"Oxford was responsive, flexible and competitively priced. Their stable financial backing makes it possible to rely on a long-term relationship. They‘re straight shooters, fair, honest and get the deal done."
David Nassif, Executive Vice President
& Chief Financial Officer Zogenix
|
|
|
|
 |
|
"Oxford was great at meeting or exceeding deliverables, and their terms were better than anyone else out there. They were honest about what could and couldn’t be done, and kept us informed throughout the lending process. The Oxford team really understood my business which made it much easier for us to achieve our financial goals."
Tina Fiumenero, Chief Financial Officer Vitae Pharmaceuticals
|
|
|
|
 |
|
"This company
definitely assess risk differently from their competitors, and
does a great job with their due diligence early on and throughout the relationship. Their affiliation with Sumitomo will be instrumental in our search for a partner in Japan. I would advise companies looking for debt to look at all options, but they’ll probably end up with Oxford because they are the best.
"
Jason Wilson, Vice President of Finance Reata Pharmaceuticals
|
|
|
|
 |
|
"When doing
business with Oxford, we were
able to talk
directly to the decision makers
so the deal moved along quickly.
They were focused on the future
of our business and
offered us the fairest deal in
town."
Thomas Insley,
Senior Vice President & Chief
Financial Officer SkinMedica
|
|
|
|
 |
|
"Oxford is great to work with, and they are more flexible than banks since they don’t have the same constraints. They really understand how biotech
and healthcare companies work, and move quickly to get the deal done."
Dennis Bourgeault, Chief Financial Officer Isotechnika
|
|
|
|
 |
|
"After looking at five or six competing proposals, Oxford simply presented us with the best product, and they work hard to build and maintain relationships with their clients. I appreciated their ability to move the deal along quickly and decisively."
Kevin Nickels, President
& Chief Executive Officer Celleration
|
|